| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Trillium Therapeutics Inc. | Chief Development Officer | Stock Option (Right to Buy) | 0 | 17 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRIL | Trillium Therapeutics Inc. | 17 Nov 2021 | 5 | $0 | 4 | Chief Development Officer | 19 Nov 2021, 12:24 |